10/03/2022
8:20 AM | Ligand Pharmaceuticals (Subject)
| Form 425
| |
10/03/2022
8:18 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2022
6:59 PM | Ligand Pharmaceuticals (Reporting)
OmniAb, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/30/2022
4:13 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2022
3:17 PM | Ligand Pharmaceuticals (Filer)
| Form S-3ASR
| |
09/22/2022
7:32 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4/A
| |
09/16/2022
6:49 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2022
4:21 PM | Avista Public Acquisition Corp. II (Subject)
Avista Public Acquisition Corp. II (Subject)
Ligand Pharmaceuticals (Filed by)
| Form 425
| |
08/09/2022
3:13 PM | Ligand Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/06/2022
7:00 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/06/2022
7:00 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2022
5:32 PM | Haas Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2022
6:33 PM | Haas Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/29/2022
4:17 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2022
7:00 AM | Ligand Pharmaceuticals (Subject)
| Form 425
| |
06/21/2022
5:19 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2022
4:55 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2022
4:55 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2022
4:55 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2022
4:54 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:47 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:47 PM | Boyce Sarah (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:47 PM | Cochran Jennifer R. (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:46 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:46 PM | Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:45 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:45 PM | LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
5:45 PM | Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2022
7:44 AM | Ligand Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2022
6:05 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2022
4:33 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
7:10 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
7:10 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
7:10 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
7:09 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2022
3:08 PM | Ligand Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/05/2022
6:30 AM | Avista Public Acquisition Corp. II (Subject)
Avista Public Acquisition Corp. II (Subject)
Ligand Pharmaceuticals (Filed by)
| Form 425
| |
05/04/2022
3:03 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2022
3:12 PM | Ligand Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/22/2022
3:11 PM | Ligand Pharmaceuticals (Filer)
| Form DEF 14A
| |
07/21/2021
8:05 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2021
7:19 PM | Cochran Jennifer R. (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2021
5:15 PM | Cochran Jennifer R. (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/14/2021
3:08 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2021
1:26 PM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:39 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:25 PM | Boyce Sarah (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:25 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:24 PM | Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:24 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/07/2021
8:24 PM | LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2021
8:23 PM | Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2021
7:57 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2021
3:11 PM | Ligand Pharmaceuticals (Filer)
| Form DEFA14A
| |
02/23/2021
4:18 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
5:28 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
5:28 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
5:27 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2021
5:27 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2021
4:30 PM | CARDINAL CAPITAL MANAGEMENT LLC /CT (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/16/2021
8:34 AM | Ligand Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/12/2021
5:23 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/11/2021
3:42 PM | JANUS HENDERSON GROUP PLC (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/11/2021
1:54 PM | Ligand Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
02/10/2021
10:14 AM | Ligand Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/09/2021
5:08 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2021
2:06 PM | Ligand Pharmaceuticals (Subject)
WASATCH ADVISORS INC (Filed by)
| Form SC 13G
| |
02/08/2021
4:19 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/05/2021
4:03 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
4:03 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
4:02 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2021
4:02 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
6:45 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2021
3:42 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2021
6:04 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
6:03 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
6:03 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
6:02 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
6:02 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2021
3:58 PM | Ligand Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/15/2021
3:11 PM | Ligand Pharmaceuticals (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
SEELOS THERAPEUTICS, INC. (Subject)
| Form SC 13G/A
| |
01/05/2021
7:30 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2020
7:39 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/16/2020
3:19 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2020
3:13 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K/A
| |
12/09/2020
5:12 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/23/2020
7:32 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/10/2020
6:41 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2020
3:11 PM | Ligand Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020
3:19 PM | Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2020
4:01 PM | Ligand Pharmaceuticals (Filer)
| Form PRE 14A
| |
10/30/2020
3:07 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2020
7:03 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2020
9:52 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/13/2020
7:44 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2020
5:30 AM | Ligand Pharmaceuticals (Reporting)
Pfenex Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2020
8:17 AM | Ligand Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
10/01/2020
7:42 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2020
7:06 AM | Ligand Pharmaceuticals (Filed by)
Pfenex Inc. (Subject)
| Form SC TO-T/A
| |
09/23/2020
7:06 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
